# Evaluation of [18F] FEPPA and PET Imaging as a Marker of Inflammation in Subjects With Neurological Conditions

> **NCT00970333** · PHASE1 · COMPLETED · sponsor: **Institute for Neurodegenerative Disorders** · enrollment: 3 (actual)

## Conditions studied

- Alzheimer Disease
- Parkinson Disease
- Multiple Sclerosis

## Interventions

- **DRUG:** [18F]-FEPPA

## Key facts

- **NCT ID:** NCT00970333
- **Lead sponsor:** Institute for Neurodegenerative Disorders
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-08
- **Primary completion:** 2010-10
- **Final completion:** 2010-10
- **Target enrollment:** 3 (ACTUAL)
- **Last updated:** 2012-02-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00970333

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00970333, "Evaluation of [18F] FEPPA and PET Imaging as a Marker of Inflammation in Subjects With Neurological Conditions". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT00970333. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*